Vanguard Group’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.3M Buy
4,328,505
+254,947
+6% +$844K ﹤0.01% 2719
2025
Q1
$11.8M Sell
4,073,558
-273,196
-6% -$792K ﹤0.01% 2753
2024
Q4
$15.5M Buy
4,346,754
+82,958
+2% +$295K ﹤0.01% 2717
2024
Q3
$21.2M Buy
4,263,796
+36,124
+0.9% +$180K ﹤0.01% 2568
2024
Q2
$11M Buy
4,227,672
+985,101
+30% +$2.56M ﹤0.01% 2858
2024
Q1
$13.8M Buy
3,242,571
+1,353,518
+72% +$5.77M ﹤0.01% 2783
2023
Q4
$3.82M Buy
1,889,053
+190,401
+11% +$385K ﹤0.01% 3390
2023
Q3
$2.6M Buy
1,698,652
+138,984
+9% +$213K ﹤0.01% 3499
2023
Q2
$2.57M Buy
1,559,668
+249,082
+19% +$411K ﹤0.01% 3582
2023
Q1
$1.49M Buy
1,310,586
+65,854
+5% +$75.1K ﹤0.01% 3784
2022
Q4
$1.12M Buy
1,244,732
+63,192
+5% +$57K ﹤0.01% 3868
2022
Q3
$1.38M Sell
1,181,540
-100,966
-8% -$118K ﹤0.01% 3889
2022
Q2
$820K Hold
1,282,506
﹤0.01% 4150
2022
Q1
$3.35M Buy
1,282,506
+40,317
+3% +$105K ﹤0.01% 3724
2021
Q4
$4.83M Buy
1,242,189
+187,885
+18% +$731K ﹤0.01% 3630
2021
Q3
$4.6M Buy
1,054,304
+8,226
+0.8% +$35.9K ﹤0.01% 3717
2021
Q2
$4.15M Buy
1,046,078
+189,652
+22% +$753K ﹤0.01% 3685
2021
Q1
$4.45M Sell
856,426
-37,969
-4% -$197K ﹤0.01% 3588
2020
Q4
$4.79M Buy
894,395
+33,485
+4% +$179K ﹤0.01% 3380
2020
Q3
$4.18M Buy
860,910
+121,138
+16% +$588K ﹤0.01% 3238
2020
Q2
$3.6M Buy
739,772
+112,964
+18% +$549K ﹤0.01% 3241
2020
Q1
$1.37M Buy
626,808
+34,400
+6% +$75.4K ﹤0.01% 3412
2019
Q4
$3.45M Buy
592,408
+312,996
+112% +$1.82M ﹤0.01% 3290
2019
Q3
$889K Sell
279,412
-32,719
-10% -$104K ﹤0.01% 3682
2019
Q2
$1.31M Sell
312,131
-81,513
-21% -$342K ﹤0.01% 3590
2019
Q1
$2.72M Buy
393,644
+54,196
+16% +$374K ﹤0.01% 3354
2018
Q4
$2.14M Sell
339,448
-120,584
-26% -$760K ﹤0.01% 3354
2018
Q3
$8.06M Buy
+460,032
New +$8.06M ﹤0.01% 3028